Disability

Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X

CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary,...

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses,...

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive feedback supporting a regulatory pathway...

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc

Ottobock Releases One of the First-Ever Community-Built Image Libraries to Improve Representation of People with Limb Loss and Limb Differences in AI

The #DearAI , powered by Microsoft, built and annotated by people with limb loss and limb differences, is now publicly...

BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism

Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...

Foundation for Sarcoidosis Research Announces New Partnership with Patient Advocate Foundation to Expand Insurance and Disability Support for Sarcoidosis Patients

CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding...

American Disabilities Testing Association Expands LSAT Accommodations Services for Candidates with Anxiety-Related Conditions with the Launch of LSATaccommodations.com

New evaluations support LSAT extended time, additional breaks, and remote testing requests for law school applicants MIAMI, FL / ACCESS...

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...

Shore Medical Center First in New Jersey to offer the VELYS™ Active Robotic Assistance Technology for Spinal Procedures

Next generation, dual-use robotics and navigation platform allows for surgical guidance tailored to surgeon preference and the patient SOMERS POINT,...

The National Paralysis Resource Center, operated by the Christopher & Dana Reeve Foundation, Announces Last Quality of Life Grants Program Awardees as Part of Current Federal Funding Cycle

error: Content is protected !!